und optimistischer Ausblick Dr├Ągerwerk share: Solid numbers, increased dividend and optimistic outlook

Last Updated: 7. M├Ąrz 2024By

The Dr├Ągerwerk share has started the trading day positively after the overall good business figures and is currently trading at around 48 euros, around 3 percent higher than yesterday. However, for the past 2 years, the stock has been in a sideways trend (as of March 7, 2024, around 10 am).

It is questionable whether the share of the medical technology company from L├╝beck will perform significantly better in the coming quarters. Although the company is back in the profit zone, the outlook for 2024 is rather solid. Important for investors: Dr├Ągerwerk significantly increases its dividend.

Dr├Ągerwerk back to making profits With 3.4 billion euros, Dr├Ągerwerk achieved around 13 percent more revenue in the 2023 financial year than in the previous year. The EBIT also looked much better recently: After the company had to record a significant loss (just under 89 million euros) in 2022, the EBIT for 2023 was at around 166 million euros – this corresponds to an EBIT margin of 4.9 percent in the last year.

In the current year 2024, growth is expected to slow down slightly. In early 2023, there was a surge in demand for ventilators in China, which will not be the case in 2024. Dr├Ągerwerk expects an increase in sales between 1 and 5 percent and an EBIT margin between 2.5 and 5.5 percent. The company also forecasts an annual increase in margin of around 1 percent.

Dr├Ągerwerk share: The dividend is also appealing Overall, after the problems in 2022, Dr├Ągerwerk completed a very good 2023 financial year and is looking at a solid to optimistic future. This offers opportunities for the Dr├Ągerwerk share. And the dividend is also attractive: 1.74 euros per common share and 1.80 euros per preferred share are to be distributed.

This corresponds to a dividend yield of just over 3.5 percent at the current price of the Dr├Ągerwerk share. Investors should not expect wonders from the medical technology share in the next quarters, but Dr├Ągerwerk is back on track overall.

Source: https://aktienscreener.com/